Bioelectronics Corp is selling for 4.0E-4 as of the 5th of January 2026. This is a 33.33% increase since the beginning of the trading day. The stock's lowest day price was 3.0E-4. Bioelectronics Corp has more than 68 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 6th of November 2025 and ending today, the 5th of January 2026. Click here to learn more.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. The company has 24.71 B outstanding shares. More on Bioelectronics Corp
Bioelectronics Corp [BIEL] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioelectronics Corp's market, we take the total number of its shares issued and multiply it by Bioelectronics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioelectronics Corp conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 24.71 B outstanding shares.
Bioelectronics Corp currently holds about 925 in cash with (320.3 K) of positive cash flow from operations.
Check Bioelectronics Corp Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Bioelectronics Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Idea Breakdown Now
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.